Current Therapeutic Progress of CDK4/6 Inhibitors in Breast Cancer

Overview of attention for article published in Cancer Management and Research, May 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#47 of 2,083)
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 2 news outlets

patent: 1 patent

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 58 Mendeley

Summary News Patents Dimensions citations

So far, Dimensions has found 41 publications that cite this research output.

41

The most recent citing publications are shown below. View all 41 publications that cite this research output on Dimensions.

Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior phosphoinositide 3-Kinase inhibitor treatment for metastatic breast cancer

Article in Breast Cancer Research and Treatment (February 2024)

Experimental and clinical evidence in favour of an effective immune stimulation in ER-positive, endocrine-dependent metastatic breast cancer

Article in Frontiers in Immunology (January 2024)

Targeted Therapies and Drug Resistance in Advanced Breast Cancer, Alternative Strategies and the Way beyond

Article in Cancers (January 2024)